Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Cefepime (BMY-28142): Neurotoxicity, CNS Models, and Assay P
2026-05-13
Explore how Cefepime (BMY-28142) empowers advanced neurotoxicity studies and central nervous system infection models. This in-depth guide reveals best practices, mechanistic insights, and protocol parameters for rigorous research applications.
-
25-Hydroxycholesterol Orchestrates Macrophage Immunometaboli
2026-05-13
Xiao et al. (2024) reveal how 25-hydroxycholesterol accumulates in tumor-associated macrophages, activating AMPKα via a lysosomal pathway to drive immunosuppressive polarization and limit antitumor immunity. Their mechanistic insights spotlight CH25H as a metabolic checkpoint, with translational relevance for immunotherapy combinations.
-
Q-VD(OMe)-OPh: Precise Caspase Inhibition for Apoptosis Assa
2026-05-12
Q-VD(OMe)-OPh redefines apoptosis research with broad-spectrum, non-toxic caspase inhibition and robust reproducibility in both in vitro and in vivo models. Its superior potency and workflow flexibility empower advanced studies in cancer resistance and neuroprotection, outperforming legacy inhibitors.
-
Lactate Drives HMGB1 Modification and Exosomal Release in Se
2026-05-12
This study reveals that lactate actively promotes both lactylation and acetylation of HMGB1 in macrophages during polymicrobial sepsis, leading to enhanced exosomal release and increased endothelial permeability. These findings highlight lactate-associated pathways as potential therapeutic targets in inflammatory signaling and sepsis intervention.
-
Azathramycin A: Precision Tool for Protein Synthesis Inhibit
2026-05-11
Explore Azathramycin A, a macrolide antibiotic uniquely suited for probing Mycobacterium tuberculosis protein synthesis inhibition and resistance mechanisms. This article delivers advanced analytical guidance for assay design and resistance modeling.
-
Pregnenolone Carbonitrile: PXR Agonist for Hepatic and Water
2026-05-11
Pregnenolone Carbonitrile (PCN) extends beyond classic xenobiotic metabolism studies, enabling precise control over hepatic detoxification and water balance pathways. Learn how this gold-standard PXR agonist empowers advanced experimental designs, with actionable troubleshooting and best-practice insights for robust, reproducible results.
-
HBTU in Peptide Bond Formation: Workflow, Performance & Tips
2026-05-10
HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) is a gold-standard peptide coupling reagent, enabling high-yield, racemization-resistant synthesis even for complex and enzyme-responsive peptides. This guide translates current research advances into practical workflows, protocol optimizations, and troubleshooting strategies for researchers seeking robust peptide bond formation.
-
Applied Tofacitinib Citrate (CP-690550 citrate) in Immune Re
2026-05-09
Tofacitinib citrate (CP-690550 citrate) offers bench researchers nanomolar JAK3 inhibition for dissecting immune regulation and inflammatory disorder pathways. This guide translates cutting-edge comparative vascular safety data and hands-on protocol refinements into actionable workflows, troubleshooting, and optimization tips for reliable immune modulation studies.
-
IGF2BP3–FZD1/7 Axis Drives Stemness and Chemoresistance in T
2026-05-09
This study identifies IGF2BP3 as a dominant m6A reader stabilizing FZD1/7 transcripts, thereby promoting cancer stem-like properties and carboplatin resistance in triple-negative breast cancer (TNBC). Targeting this axis may improve therapy efficacy by sensitizing TNBC stem cells to chemotherapy while reducing toxicity.
-
Meropenem: Applied Workflows in β-Lactam Carbapenem Research
2026-05-08
Meropenem, an ultra-broad-spectrum β-lactam antibiotic carbapenem, enables robust modeling of Gram-negative and Gram-positive bacterial resistance in both basic and translational research. This guide details stepwise experimental enhancements, protocol-critical parameters, and troubleshooting strategies that maximize Meropenem’s reliability for resistance and septicemia studies.
-
Temozolomide: Alkylating Agent for DNA Repair & Glioma Model
2026-05-07
Temozolomide is a validated small-molecule alkylating agent used to induce DNA damage in cancer model research. Its spontaneous methylation of guanine bases makes it indispensable for studying DNA repair mechanisms and chemotherapy resistance. APExBIO's Temozolomide supports reproducible workflows in glioma and oncology studies.
-
Bay 11-7821 (BAY 11-7082): Precision IKK Inhibition for Canc
2026-05-07
Bay 11-7821 (BAY 11-7082) empowers researchers with robust, selective inhibition of the NF-κB pathway, enabling reproducible dissection of inflammation and apoptosis in cancer and immunology models. Its versatility in cell-based and in vivo workflows—combined with actionable troubleshooting and optimization tips—makes it an essential tool for next-generation translational research.
-
Caspase-3 Fluorometric Assay Kit: Workflow & Applied Insight
2026-05-06
Leverage the Caspase-3 Fluorometric Assay Kit for rapid, quantitative assessment of apoptosis and caspase signaling in complex disease models. This guide delivers protocol optimizations, troubleshooting strategies, and actionable insights based on recent mechanistic breakthroughs and expert workflows.
-
Dual Luciferase Reporter Gene System: Precision in Osteogeni
2026-05-06
The Dual Luciferase Reporter Gene System empowers researchers to dissect transcriptional events and regulatory pathways with unmatched sensitivity. This article details protocol enhancements and troubleshooting tips for high-throughput luciferase detection, drawing on recent breakthroughs in stem cell osteogenesis.
-
Dual Luciferase Reporter Gene System: High-Throughput Insigh
2026-05-05
Unlock precise normalization and high-throughput transcriptional studies with the Dual Luciferase Reporter Gene System. This assay enables robust, sequential bioluminescence analysis, allowing researchers to dissect complex regulatory pathways with confidence.